Global Health
Stock Snapshot
Price Performance
Vista Outlook
Basis of our Recommendation
Global Health (Medanta) is navigating a robust growth trajectory, underpinned by a strategic focus on expanding its multi-specialty hospital network in underpenetrated markets. Management's commitment to enhancing bed capacity by nearly 95% over the next few years, particularly in Tier-2 and Tier-3 cities, addresses the structural demand-supply imbalance in Indian healthcare. This expansion is complemented by significant investments in medical technology and AI-driven diagnostics, which are expected to bolster operational efficiency and patient care quality. Vista's financial outlook reflects stable revenue growth and margins, supported by the company's disciplined capital allocation and strong brand equity. However, potential headwinds include execution risks associated with large-scale infrastructure projects and rising operational costs. The healthcare sector's overall growth, driven by increasing demand for organized care, aligns with Vista's forecast of a 22.65% expected upside, with a 12-month target price of INR 1,738. Key opportunities lie in the maturation of new facilities and the expansion of high-acuity services, while watchpoints include regulatory pressures and competitive dynamics in the healthcare landscape
Why We Like This Stock
- Strategic expansion into underpenetrated markets is expected to significantly enhance capacity and revenue
- Strong operational momentum and brand equity provide a competitive advantage in a growing healthcare sector
- Management's disciplined capital allocation and focus on high-acuity services support long-term growth potential
Things To Watch Out For
- Execution risks associated with large-scale infrastructure projects could impact profitability timelines
- Rising operational costs and regulatory pressures may challenge margin stability
- Intensifying competition in mature markets could affect market share and pricing power
Key Parameters
Financial Snapshot
View Technicals Analysis →| Actuals | Forecast | ||||
|---|---|---|---|---|---|
| FY24 | FY25 | FY26 | FY27 | FY28 | |
| Revenue (Cr.) | 3,275 | 3,692 | 4,410 | 4,889 | 5,673 |
| Profit Before Tax (Cr.) | 626 | 697 | 714 | 808 | 1,006 |
| PBT Margin | 19.1% | 18.9% | 16.2% | 16.5% | 17.7% |
| Net Profit (Cr.) | 448 | 523 | 580 | 652 | 812 |
| Earnings Per Share | 16.7 | 19.5 | 21.6 | 24.3 | 30.2 |
Analyst Recommendations
| Broker | Recommendation | Target Price | Date |
|---|---|---|---|
| Investec | ▲ Buy | 1,730 | 18-Sep-2026 |
| Prabhudas Liladhar | ▲ Buy | 1,750 | 26-Aug-2026 |
| JPMorgan | ▲ Buy | 1,650 | 04-Aug-2026 |
| ICICI Securities | ▲ Buy | 1,650 | 03-Aug-2026 |
| Moneycontrol | ▲ Overweight | nan | 03-Aug-2026 |
| Jeffries | ▲ Buy | 1,660 | 01-Aug-2026 |
| Motilal Oswal | ▲ Buy | 1,670 | 01-Aug-2026 |
| Anand Rathi | ▲ Buy | 1,400 | 19-May-2026 |
| Choice Equity | ▲ Buy | 1,460 | 18-May-2026 |
| HSBC | ► Hold | 1,120 | 21-Apr-2026 |
Company Overview
Show Company Profile
Global Health Limited, together with its subsidiaries, provides healthcare services in India. The company offers treatments in the areas of digestive and hepatobiliary sciences, cardiac and cancer care, neurosciences, gastrosciences, orthopaedics, renal care, liver transplant, lung transplant, bone marrow transplant, chest surgery, gynaecology and gynaeoncology, paediatric care, obstetrics, emergency, ENT, head and neck surgery, internal medicine, respiratory and sleep medicine, peripheral vascular and endovascular sciences, endocrinology and diabetes, rheumatology and immunology, radiology and imaging, ophthalmology, critical care, dermatology, dentistry, lab and pathology, and dietetics and nutrition, as well as plastic, aesthetic, and reconstructive surgery. It also provides second opinions, lab tests and diagnostics, homecare and elder care services, telemedicine and air ambulance services, and e-ICU services, and health plans checkup services. In addition, the company is involved in trading pharmacy and other medical consumables; and medical and healthcare education activities. The company operates a network of hospitals under the Medanta brand. Global Health Limited was incorporated in 2004 and is based in Gurugram, India.